CLINICAL_TRIALS trial_result · 2020-03-24

Clinical Trial Update: Prospective Biomarkers of Bone Metabolism in Hemophilia A [Phase 3]

A Phase 3 trial evaluating prospective biomarkers of bone metabolism in individuals with Hemophilia A has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Oregon Health and Science University | Conditions: Hemophilia, Bone Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-03-24